Latest News in Pharma industry

10 hours ago

Cylib Raises €55M in Series A Funding

10 hours ago

Duke University's Promising HIV Vaccine

10 hours ago

Turkey's New Crypto Oversight Legislation

11 hours ago

Voyager Therapeutics Initiates Phase Ia Clinical Trial for VY-TAU01 in Alzheimer's Patients

20 hours ago

MakerDAO Announces PureDai Launch

20 hours ago

AstraZeneca's SuperNova Trial: Promising Results for Sipavibart

1 day ago

U.S. House Committee Passes New Biosecurity Bill

1 day ago

Uniquity Bio Receives $300M Funding for Solrikitug Drug Trials

1 day ago

H5N1 Virus Found in Wild Birds in NYC

1 day ago

Roche's CT-388 Shows 18.8% Mean Weight Loss in Phase Ib Trial

1 day ago

Vanda Pharmaceuticals Reports Positive Results for Motion Sickness Drug

1 day ago

Humanity Protocol: Revolutionizing Digital Identity Verification

1 day ago

Japan's Q1 2024 GDP Contracts

1 day ago

Fast-Fashion Giant Shein Faces Labor Standard Scrutiny

1 day ago

Lack of Diversity in Clinical Trials: FDA Releases 2023 Drug Trials Report

2 days ago

Weka Raises $140M to Revolutionize AI Data Management

2 days ago

Shiba Inu Team's Take on Altcoin Season

2 days ago

WuXi AppTec's Controversies: Ties to NextCode and Huawei

2 days ago

UN Reports $147.5M Cryptocurrency Laundering by North Korea

2 days ago

Verismo Therapeutics Cleared for SynKIR-310 Trial

2 days ago

US Inflation Up 0.3% in April

2 days ago

Pharma Companies to Unveil Clinical Trial Data at 2024 ASCO Annual Meeting

2 days ago

Edinburgh Startup Malted AI Raises £6M for Specialized GenAI Models

2 days ago

Future of circRNA: Vaccines, Therapeutics, and Beyond

2 days ago

Roche CEO Criticizes Switzerland's Tax Policy

3 days ago

Study Reveals Surprising Disconnect in Dengue Transmission

3 days ago

Phorpiex Phishing Campaign Spreading LockBit 3.0 Ransomware

3 days ago

Kodiak Sciences Initiates Phase III GLOW2 Trial for Diabetic Retinopathy Treatment

3 days ago

Dandelion Health's AI Database for GLP1-RAs Investigation

4 days ago

BMS Cancer Immunotherapies Opdivo and Yervoy Face Setback in Phase III Trial

4 days ago

Several Pharma Companies See Success in Clinical Trials This Week

6 days ago

Macrogenics' Stock Plummets 77.4%

7 days ago

Stanford Researcher Calls for Consortium to Reject 'Glam Journals' After AlphaFold3 Hype

7 days ago

China Announces New Data Security Rules for Accounting Firms

7 days ago

Freeline Therapeutics Reveals Positive Gene Therapy Data

7 days ago

Takeda Pharmaceutical Co. Unveils Restructuring Plan

7 days ago

EU-X-CT Project Launched for Cross-Border Clinical Trials

7 days ago

Fusion Pharmaceuticals Initiates Phase II AlphaBreak Trial for FPI-2265

7 days ago

Pfizer Settles 10,000 Zantac Lawsuits

7 days ago

Merck's Keytruda Trial Fails in Endometrial Cancer

8 days ago

AlphaFold 3 Debunked: Revolutionary or Overhyped?

8 days ago

Freepik Acquires Magnific AI: Accelerating Growth

8 days ago

Sangamo Introduces MINT Platform for Precise Genome Editing

8 days ago

Soy Protein Isolate Prices Decline Amid Weak Demand

8 days ago

Regeneron's DB-OTO Gene Therapy Shows Promise in Treating Otoferlin Hearing Loss

8 days ago

Regenex Bio's RGX-2 Gene Therapy Phase III Trial Design Ready

8 days ago

Potassium Sorbate Price Plummets

8 days ago

Genprex CEO Rodney Varner Passes Away

9 days ago

DeepMind's AlphaFold 3 Revolutionizes Modeling Biological Molecules

9 days ago

Sanofi's Rilzabrutinib: A Promising Cancer-Fighting Drug